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Introduction
============

Pharmaceuticals are regularly found in the aquatic environment[@B0][@B1][@B2][@B3][@B4]. An important source are effluents from wastewater treatment plants (WWTP)[@B5][@B6][@B7][@B8]. The occurrence of pharmaceuticals in the throughout the water cycle has been studied exemplarily in the Turia River Basin[@B9]. Among others, antibiotics represent a particular hazardous class of drugs, since they often pass the biological stage of WWTPs unaltered and may cause bacterial resistances in the environment[@B10][@B11][@B12]. Macrolides constitute a class of antibiotic drugs that are applied both in human and in veterinary medicine. Their representatives were found in concentration up to 1 µg/L in effluents[@B13][@B14][@B15][@B16][@B17][@B18]. One of them is erythromycin (Ery)[@B19][@B20]. In waters, erythromycin is often accompanied by anhydroerythromycin A (Ery A - H~2~O), a dehydrate[@B21][@B22]. Water elimination from erythromycin is due to acid instability. The ratio of erythromycin vs. anhydroerythromycin depends on the pH[@B23][@B24][@B25][@B26].

Chemically, macrolides contain a macrocylic lactone to which various sugar moieties are attached, *e.g*., desosamine, cladinose or mycaminose. Since macrolides are chemically modified natural products from fermentation processes, they often exist as mixtures. The species termed A, B, C, *etc*., differ in the sugar substituents. The sugar moieties and their position at the lactone are responsible for the mode of action of macrolides[@B27][@B28]. In order to minimize environmental hazard, it is desirable to completely mineralize the pharmaceuticals before entering the aquatic environment[@B26][@B29][@B30][@B31].

The first part of this study deals with the detection of pharmaceutical in surface waters, which is important for monitoring both effluents and open waters. To search for a variety of unidentified substances in the microgram range in different matrices, non-targeted analysis is the method of choice[@B19][@B32][@B33][@B34]. In particular, high-performance liquid chromatography (HPLC) electrospray ionization quadrupole time of flight mass spectrometry (HPLC-ESI-Q-TOF-MS) has been proved of extraordinary value due to its specificity and sensitivity. After the identification of the substance, sensitivity can further be extended by using the targeted MS approach with the quadrupole operated in select mode and the collision energy within the collision cell set to zero. Hence, ions arrive non-fragmented at the TOF detector.

The second focus of this work is the elimination of erythromycin. For the elimination of the pharmaceuticals, so-called advanced oxidation processes (AOPs) are used, *e.g*., started by irradiation with UV light[@B35][@B36][@B37]. Essential for the degradation is the formation of hydroxyl radicals from water by VUV / UVC irradiation following eq. 1.

H~2~O + h*ν*(\<200 nm) → H~2~O\* → H**^.^** + **^.^**OH        (1)

Hydroxyl radicals possess a high oxidation potential of 2.8 V, which positively contributes to the degradation of the substances[@B35][@B36].

Here, the degradation of erythromycin using vacuum UV/UVC-irradiation in water is described taking the influences of the pH into account. The formation of even more hazardous products is believed to be a disadvantage of using AOPs[@B38][@B39]. Thus, it is important to irradiate until complete mineralization of the pharmaceuticals. To better estimate the irradiation time, the kinetic model of the reaction, the reaction rate constants and the half-lives are determined both for the initial drug and for its photodegradates. To this purpose, concentration-time (c-t) plot were derived from HPLC-ESI-Q-TOF-MS measurements and compared to chemical kinetics models using MATLAB. The kinetics of the degradation proceeded according to first-order, and the photodegradates were described as intermediate products of a consecutive or subsequent follow-up reaction[@B26][@B40].

Protocol
========

1. Sample Preparation: Solid Phase Extraction
---------------------------------------------

1.  Collect about 1 L of water for the preparation of the samples.

2.  Filter the sample over a blue band filter with a pore size of 2 µm to remove coarse particles.

3.  Equilibrate the SPE cartridge using 3 mL of methanol and 3 mL of ultrapure water.

4.  Apply the filtrate (1 L) onto the SPE cartridge and increase the flow velocity using a moderate vacuum, *e.g*., a diaphragm pump. NOTE: Several SPE cartridges may be run in parallel.

5.  Wash the sample with 3 mL of ultrapure water.

6.  Elute the analytes from the cartridge sorbate with 3 mL of methanol.

7.  Concentrate the 3 mL eluate to dry using a rotary evaporator.

8.  Dissolve the residue in 1 mL of ultrapure water.

9.  Filter the solution through a syringe filter and store them in a vial for the non-targeted analysis by HPLC-ESI-Q-TOF-MS.

2. HPLC-ESI-Q-TOF-MS Method for Non-Targeted and Targeted Analysis, and MS/MS
-----------------------------------------------------------------------------

1.  Transfer the vial to the HPLC-ESI-Q-TOF-MS autosampler.

2.  Set all relevant parameters (**Table 1**) for the HPLC-ESI-Q-TOF-MS. NOTE: If a finite collision energy is used, *i.e*., collision energy (CE) ≠ 0, ions will be fragmented. This mode corresponds to the targeted MS/MS method.

3.  Start the measurement.

4.  Analyze the resulting chromatograms and mass spectra.

3. UV Irradiation Experiments
-----------------------------

1.  Dissolve the antibiotic compound, *e.g.,* erythromycin (750 mg/L), in ultrapure water at 20 mg/L final concentration.

2.  Fill the 1 L photoreactor, wrapped in aluminum foil, with 750 mL of the solution.

3.  Introduce the lamp providing 15 W of power into the reactor.

4.  Apply the magnetic stirrer at 500 rpm.

5.  Adjust the pH value to the desired value 3-4, 6-7 or 8-9 by dropwise addition of HCl (0.1 M) or NH~3~ (0.1 M) if necessary. pH 6-7 is used as an example.

6.  Take 2 mL of the reaction solution as sample at time 0 using a syringe and transfer it into a 2 mL glass vial.

7.  Switch on the UV lamp and keep track of the elapsing time. NOTE: Irradiation times of 10 min are often sufficient. If completeness of the photoreaction is desired, a second experiment series might need to be recorded using the results of the first series. Caution: UV irradiation may lead to blindness.

8.  Draw a 2 mL sample from the solution every 30 s during the first 5 min. Then, take a sample every 60 s until the end of the experiment. Transfer the samples into 2 mL vials.

9.  Store the vials until HPLC-ESI-Q-TOF-MS analysis at -4 °C.

10. Analyze the 16 samples using HPLC-ESI-Q-TOF-MS with the methods described in step 2.

4. Kinetics Analysis
--------------------

1.  Prepare a suitable software such as the curve-fitting toolbox of MATLAB R2016b.

2.  Fit the mass-area vs. time data of the photo-induced degradation of the parent antibiotic compound according to first order kinetics, see eq. 2[@B41][@B42]    (2) The concentration refers to the initial concentration of the educt A, *c~A~* to the actual concentration over the reaction time *t* with the rate constant *k*~1~ from the first reaction step A to B.

3.  Fit the mass-area vs. time curves of the degradates using eq. 3 and 4, as they can be described as intermediates of a consecutive or subsequent follow-up reaction, *i.e*., product B or C according to the reaction model A →B → C → D.    (3)    (4) The concentrations*c*~B~ and *c*~C~ refer to the intermediates B and C; and *k*~2,~*k*~3~ to the corresponding rate constants B to C, C to D.

4.  Use eq. 5 to fit the data, if the irradiation time was not sufficient to observe the degradation of a photo-product. This degradate can be treated as final product D with the concentration *C*~D~ to obtain rate constants.    (5) Calculate the concentration of B using eq. 6 instead of eq. 3, if the reaction ends with B. If C is the final product, calculate the concentration of C according to eq. 7 instead of eq. 4.    (6)    (7)

5.  Use eq. 8 for the determination of the half-lives *t*~1/2~.    (8)

Representative Results
======================

As result of the solid phase extraction, a yellowish to dark green solution was obtained in all cases, which indicated the presence of chlorophyll-containing substances ([Figure 1](#F1){ref-type="fig"}). Pharmaceuticals contained in this water sample would not lead to visible coloration since their concentration and their absorbance would generally be too low. Instead, the occurrence of pharmaceuticals needs to be analyzed using HPLC and high-resolution mass spectrometry.

In non-targeted analysis, a HPLC-ESI-Q-TOF-MS was used because of its outstanding mass accuracy allowing to obtain the accurate mass for each compound ion. The mass-detected chromatogram of the performed analysis was represented as a base peak chromatogram (BPC), which displays the most intense peak of each mass spectrum recorded in the course the chromatographic separation. The example shown in [Figure 2](#F2){ref-type="fig"} presents the BPC of a water sample from the river Rhine.

The BPC contained more than twenty-five peaks reflecting different m/z values, hence different compounds, seven of which were marked in the BPC. Since the substances were unknown *a priori*, the first step to their identification usually consists of deriving the molecular formula. This is accomplished through accurate mass and isotopic pattern provided by the TOF detection, although the isotopic pattern may not be observed in all cases due to low sample concentrations in environmental samples. With the help of public database, such as Pharmaceuticals in the Environment by the German Environment Agency (UBA) containing approximately 630 compounds, a preliminary identification of a small group of candidates is often successful. For a final proof, either comparison to commercially available reference standards may be performed or MS/MS fragmentation patterns may be considered ([Figure 3](#F3){ref-type="fig"}).

In this work, comparison to standards with respect to retention time accounted for the identification of pharmaceuticals very often found in German surface waters. These substances include metoprolol, a β-blocker, carbamazepine, an analgesic, and the macrolide antibiotic erythromycin A and its derivate anhydroerythromycin A. Erythromycin serves as example further investigated in this study. The studied Rhine river sample had a pH of 7.6 and an average temperature of 16.5 °C. At this pH, anhydroerythromycin would also be expected to be present in the water sample. For the detailed analysis, the extracted ion chromatograms (EICs) of the water sample were compared with the reference standards ([Figure 4](#F4){ref-type="fig"}).

The comparison shows good agreement between the retention time for metoprolol, carbamazepine and anhydroerythromycin and the observed analytes. The EIC of the reference standard anhydroerythromycin displayed two peaks, hence two compounds where dehydration had occurred at two distinct sites of erythromycin. Yet, only one anhydroerythromycin isomer was identified in the Rhine river sample. Erythromycin itself was only present in traces. Therefore, no MS/MS spectrum could be obtained. The accurate masses for the antibiotic and its dehydrate are given in **Table 2**. Using EIC, thus m/z value and retention time, metoprolol, carbamazepin, erythromycin and anhydroerythromycin could be identified in the Rhine river sample.

With respect to the aquatic environment, it is important to prevent pharmaceuticals from passing through wastewater treatment plants and entering surface waters. In the quest for an efficient elimination, UV-C irradiation experiments at different pH values were carried out for erythromycin as example. Concentration-time (*c-t*) diagrams were recorded using mass-area vs. time plots derived from EICs. The degradation was described according to equation 2. Erythromycin consists of erythromycin A and B and anhydroerythromycin A, with two isomers of the latter. The *c-t* curves of erythromycin A and their computational fits are shown in [Figure 5](#F5){ref-type="fig"}. At pH 7,accelerated degradation was observed. This applies to all four compounds studied, data not shown. As a consequence, photo-induced degradation of erythromycin should be carried out around neutral pH. In the case of the Rhine river sample, pH adjustment was not required.

Photodegradates of the pharmaceuticals were also identified at all three pH values. An overview of these photodegradates with their corresponding structure proposals is given in Table 3. For the kinetic analysis of the photodegradates, the product with m/z = 720 serves as an example. Photodegradates can often be described as reaction intermediates. Therefore, the photodegradates were described in terms of aconsecutive and subsequent follow-up reaction. The decision between the resulting types of intermediates is based on the goodness of the fit computed with suitable software, where the coefficient of determination (R^2^) and the residual mean-squared error (RMSE) were taken as the criteria. Due to the fact that erythromycin is acid-instable, degradates as would occur upon irradiation were present prior to irradiation. The resulting effect on equations 3 and 4 was a finite starting concentration. Hence, a factor was added to the equations. [Figure 6](#F6){ref-type="fig"} shows experimental data and fits computed according to equation 3 and 4.

This example of an intermediate demonstrated the concentration increase with a sigmoidal rise followed by an exponential decay. This is indicative for a subsequent follow-up reaction intermediate. A consecutive reaction intermediate does not show the sigmoidal increase. Statistical quality parameters also indicated the slightly superior agreement of fit according to the subsequent follow-up reaction model. The coefficient of determination R^2^ of the consecutive reaction was 0.9898 and thus lower than that of the subsequent follow-up reaction being 0.9976. Therefore, the examined photoproduct was interpreted as intermediate of a subsequent follow-up reaction. The k-values resulted from the computational fit as well, the half-life was calculated following equation 5. All relevant kinetic parameters are collected in **Table 3**.

The fastest degradation was observed at pH 7, followed by pH 9, while the slowest degradation was found for pH 3 ([Figure 5](#F5){ref-type="fig"}). This finding also applied to the formation and degradation of the photoproducts. Three photodegradates were observed. Their m/z values were 750.46 corresponding to Ery F, 720.45 to Ery C and 192.12 to DPEry192, a glycosidically bound sugar of the erythromycin structure ([Figure 7](#F7){ref-type="fig"}). No degradation of the photoproduct could be observed for DPEry192 at pH 3 and 9 and for Ery F at pH 9. In these cases, the irradiation time was not sufficient long to observe total degradation of the intermediate product. Nevertheless, the formation rate constant could be determined by using equation 5, which corresponds to a final product.

[Figure 1](#F1){ref-type="fig"}**. Comparison of the samples from the Rhine river after SPE (left) and ultrapure water(right) treatment.** The green coloration is indicative for chlorophyll-containing substances. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig1large.jpg)

[Figure 2](#F2){ref-type="fig"}**. BPC of a water sample after SPE measured with HPLC-ESI-Q-TOF-MS.** All chromatograms were normalized to the highest peak. Illustrative m/z-values as obtained from the corresponding MS spectrum are marked. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig2large.jpg)

[Figure 3](#F3){ref-type="fig"}**. Q-TOF-MS spectrum of erythromycin A (bottom) and the MS/MS spectrum of the ion m/z = 734.4689 (top).**The spectra show the quasi-molecular ion of erythromycin A with its isotopic pattern and the fragments at an applied collision energy of 30 eV. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig3large.jpg)

[Figure 4](#F4){ref-type="fig"}**. Normalized EICs of (A) metoprolol, (B) carbamazepine, (C) erythromycin A and (D) anhydroerythromycin A in a Rhine river sample (blue) and in ultrapure water from reference compounds (red).** The retention times of the reference compounds and the ones of the pharmaceuticals in the water sample are the same. The signal-to-noise ratios of metoprolol (A) and anhydroerythromycin (D) are higher than those of carbamazepine (B) and erythromycin (C), which indicates the latter were present only in traces. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig4large.jpg)

[Figure 5](#F5){ref-type="fig"}**. Normalized concentration-time curves of the photodegradation of erythromycin A at pH 3 (red), pH 7 (green) and pH 9 (blue).** Solutions were irradiated for 10 min. At pH 7, erythromycin was completely removed from the sample. The concentration-time curves could be described using first-order kinetic equations. The kinetic rate constants were 0.10 (pH 3), 0.59 (pH 7) and =0.21 (pH 9). [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig5large.jpg)

[Figure 6](#F6){ref-type="fig"}**. Comparison of the fits of the concentration-time curves of the photoprodegradates of erythromycin with m/z = 720 at pH 9 following equations 3 (A) and 4 (B).** Goodness of the fit of the consecutive reaction (A): R^2^ = 0.9898, RMSE = 4.645E+04, and of the subsequent follow-up reaction (B): R^2^= 09976, RMSE = 2.366E+04. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig6large.jpg)

[Figure 7](#F7){ref-type="fig"}**. Structure of erythromycin A, erythromycin B and anhydroerythromycin and their photdegradation products.** This figure has been modified from Voigt *et al*.[@B26]. The products were formed after 10 min of UVC-irradiation and identified using HPLC-Q-TOF-MS and MS/MS. [Please click here to view a larger version of this figure.](/files/ftp_upload/57434/57434fig7large.jpg)

  ------------------------------------------- ------------------------------------------------- ------- ------- ------ ------ ------
  **Liquid Chromatography**                                                                                                   
  Column:                                     reversed-phase C-18                                                             
  Column:                                     CoreShell column;                                                               
  Column:                                     50 mm x 2.1 mm dimensions, 2.6 μm particle size                                 
  Column temperature                          40 °C                                                                           
  Injection volume:                           5 µL                                                                            
  Flow:                                       0.3 mL/min                                                                      
  Mobile phase:                               Solvent A: water containing 0.1% formic acid                                    
                                              Solvent B: methanol containing 0.1% formic acid                                 
  **Gradient program:**                                                                                                       
  Time /min                                   0                                                 1       10      11.1   11.2   12
  A:B solvent ratio                           99:1                                              70:30   25:75   1:99   1:99   99:1
  **Mass Spectrometry**                                                                                                       
  Source:                                     Dual AJS ESI (positive mode)                                                    
  **Gas and source**                                                                                                          
  Gas Temperature:                            300 °C                                                                          
  Drying Gas:                                 8.0 L/min                                                                       
  Nebulizer:                                  14 psig                                                                         
  Sheath Gas Temperature:                     300 °C                                                                          
  Sheath Gas Flow:                            8 L/min                                                                         
  Mass Range:                                 100 - 1000 m/z                                                                  
  Acquisition Rate:                           1 spectrum/s                                                                    
  Acquisition Time:                           1000 ms/spectrum                                                                
  Transient/ spectrum                         10014                                                                           
  **For targeted MS method**                                                                                                  
  Collision energy (CE):                      0 eV                                                                            
  Preferred Mass - Table                      734.4685                                                                        
  **For MS/MS (typically auto MS/MS mode)**                                                                                   
  Collision energy (CE):                      30 eV                                                                           
  Absolute threshold                          3000 counts                                                                     
  Relative threshold                          0.01 %                                                                          
  Mass Range:                                 100 - 100 m/z                                                                   
  Acquisition Rate:                           1 spectrum/s                                                                    
  Acquisition Time:                           1000 ms/spectrum                                                                
  Transient/ spectrum                         9964                                                                            
  **For targeted MS/MS method**                                                                                               
  Preferred Mass - Table                      734.4685                                                                        
  ------------------------------------------- ------------------------------------------------- ------- ------- ------ ------ ------

**Table 1. Conditions and parameters used for HPLC-ESI-Q-TOF-MS analysis of pharmaceuticals in water matrices.** It is advisable to introduce a rinsing step between the chromatographic runs through running a sample of pure ultrapure water between two analyses or through extending the run time of the chromatographic method in order to elute all substances.

**Table 2. Pharmaceuticals found in the Rhine river sample with their retention time, theoretical and observed \[M+H\]**^+^**and their structure.** The ESI mode was set to positive, so that \[M+H\]^+^-ions were detected. The retention time may vary minimally for usual experimental known reasons.

  ------------------------------------ ---------------------- --------------------------- ---------------------- ---------------------- ---------------------- --------------------------- --------------------------- --------------------------- ---------------------- ---------------------- --------------------------- ---------------------------
                                       **pH 3**               **pH 3**                    **pH 7**               **pH 7**               **pH 7**               **pH 7**                    **pH 7**                    **pH 7**                    **pH 9**               **pH 9**               **pH 9**                    **pH 9**
  **Product**                          **k~1~ \[min^-1^\]**   **t~1/2~ \[min\] (k~1~)**   **k~1~ \[min^-1^\]**   **k~2~ \[min^-1^\]**   **k~3~ \[min^-1^\]**   **t~1/2~ \[min\] (k~1~)**   **t~1/2~ \[min\] (k~2~)**   **t~1/2~ \[min\] (k~3~)**   **k~1~ \[min^-1^\]**   **k~2~ \[min^-1^\]**   **t~1/2~ \[min\] (k~1~)**   **t~1/2~ \[min\] (k~2~)**
  Ery A                                0.1                    6.81                        0.59                   \-                     \-                     1.18                        \-                          \-                          0.21                   \-                     3.37                        \-
  Ery B                                0.05                   14.23                       0.66                   \-                     \-                     1.04                        \-                          \-                          0.22                   \-                     3.21                        \-
  Ery A -- H~2~Oa                      0.11                   6.53                        0.59                   \-                     \-                     1.17                        \-                          \-                          0.19                   \-                     3.72                        \-
  Ery A -- H~2~Ob                      0.15                   4.76                        1.11                   \-                     \-                     0.63                        \-                          \-                          0.21                   \-                     3.35                        \-
  Ery F                                not observed           \-                          0.89                   0.35                   \-                     0.78                        1.98                        \-                          1.09\*                 \-                     0.64                        \-
  Ery C                                not determined         \-                          0.74                   5.27                   0.78                   0.94                        0.13                        0.89                        0.17                   0.18                   4.04                        3.92
  DPEry192                             0.35\*                 1.97                        not observed           \-                     \-                     \-                          \-                          \-                          0.30\*                 \-                     2.34                        \-
  \* No further degradation observed                                                                                                                                                                                                                                                                                         
  ------------------------------------ ---------------------- --------------------------- ---------------------- ---------------------- ---------------------- --------------------------- --------------------------- --------------------------- ---------------------- ---------------------- --------------------------- ---------------------------

**Table 3. Kinetic rate constants and corresponding half-lives of the degradation of erythromycin and its photodegradates adapted from Voigt*****et al.***[@B26]**.**Erythromycin consists of erythromycin A, erythromycin B and two forms of anhydroerythromycin. Three photodegradates were observed. There are referred to as Ery F, Ery C and DEry192.

Discussion
==========

The example of a non-targeted analysis presented in this report demonstrated the identification of pharmaceuticals in surface water using HPLC-ESI-Q-TOF-MS, MS/MS and comparison with reference standards as the final proof. The strength of non-targeted analysis using TOF-MS is based on the detection of all ions present at a given retention time and the high mass accuracy which leads to the prediction of the tentative molecular formula. As an alternative to a TOF mass spectrometer, the application of an orbital ion trap has been described for contaminant analysis in water[@B43]. The molecular formula prediction was used as the starting point to quickly select reference standards. The application of the targeted MS method of the Q-TOF-MS instrument allowed the detection of specific compounds, since only pre-selected ions pass the quadrupole filter. In general targeted analysis is performed using triple quadrupole mass spectrometer also in water analysis[@B44]. To compensate for the deviation from the theoretical mass due to instrumental imperfections, a chromatographic comparison with a reference standard might be performed. The targeted MS/MS method may also be chosen for identification analysis. Here, ions are selected, fragmented and their fragments detected. Since MS/MS is less sensitive than MS, the concentration of the pharmaceuticals in the investigated water samples was too low to yield meaningful fragments. However, if fragments are detected, compounds can be identified with higher confidence. The insufficient sensitivity might be overcome by concentrating a larger initial water sample volume. In addition, the measurement should be carried out as soon as possible after sampling because of potential biodegradation[@B45][@B46][@B47][@B48]. Otherwise, samples should be stored at -20 °C to exclude compound degradation or reaction.

Sometimes the same m/z values appear at different retention times. This may be due to that the isomers require different analytical techniques. It can also occur that no compounds might be detected at all, which does not necessarily prove their absence. They might just not form ions or occur below the limit of detection. The type of water also exercises an influence on the presence of pharmaceuticals. Pharmaceuticals rarely enter source water and groundwater as compared to sewage water and effluents from wastewater treatment plants[@B47][@B49][@B50][@B51][@B52].

For the degradation experiments, the irradiation source should be characterized in advance, since the photon flux or photon fluence rate of the lamp contributes significantly to the degradation and the mechanism of degradation. For initial attempts, a VUV/UVC lamp, probably a low-pressure mercury lamp is sufficient. In general, the addition of hydrogen peroxide, H~2~O~2,~ accelerates the degradation[@B26][@B35][@B36][@B53]. When a different lamp, *e.g*., a UVA lamp, is used, the formation of hydroxyl radicals should be ensured, *e.g*., through the addition of titanium dioxide [@B22][@B23][@B29][@B30]. For many compounds, such as erythromycin, OH radicals rather than photo-reactivity of the pharmaceutical itself[@B26]are the degradation-inducing species.

For the determination of the kinetic parameters, the area of the signals in the mass-detected chromatograms, representing concentration, is plotted versus irradiation time. To fit the data, it is advisable to use suitable software. Here, the curve fitting tool of MATLAB was used, which allowed to quickly compute and fit the data with the correct equations. The kinetic of the intermediates is determined by more complex equations. The quality parameters for the fit, *i.e*., R^2^ and RMSE, were readily obtained as well.

This study demonstrated the analysis of river water to detect and identify pharmaceutical pollutants and the photodegradation of erythromycin in ultrapure water. In environmental waters, such as surface water, different degradation velocities and rate constants would be obtained due to light absorbing substances, such as humins. According to the authors\' experience, degradation often takes place more slowly, but sometimes at comparable rates[@B40][@B55].

The worldwide problem of pharmaceuticals, especially antibiotics, in the aquatic environment and the resulting hazards still continue to grow[@B0]. Due to the variety and diversity of chemicals, metabolites, and degradates thereof, non-targeted analysis will become the most important analytical weapon for their discovery in the environment[@B56]. For the effective elimination, novel stages in wastewater treatment plants will need to be designed based on advanced oxidation processes, which UV irradiation might be part of.
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